These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1876664)

  • 1. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.
    Essig EC; Kilpatrick IC
    Psychopharmacology (Berl); 1991; 104(2):194-200. PubMed ID: 1876664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol-induced increases in rat amygdaloid dopamine metabolism: evidence for independence from postsynaptic feedback mechanisms.
    Essig EC; Kilpatrick IC
    Neurosci Lett; 1991 Feb; 123(2):261-4. PubMed ID: 2027541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
    Kurata K; Shibata R
    Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen.
    Pehek EA; Yamamoto BK
    J Neurochem; 1994 Dec; 63(6):2118-24. PubMed ID: 7964731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
    Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen.
    Yoshida Y; Ono T; Kawano K; Miyagishi T
    Brain Res; 1994 Mar; 639(1):139-48. PubMed ID: 7910107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
    Kilpatrick IC; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.
    Matsumoto T; Uchimura H; Hirano M; Kim JS; Yokoo H; Shimomura M; Nakahara T; Inoue K; Oomagari K
    Eur J Pharmacol; 1983 Apr; 89(1-2):27-33. PubMed ID: 6861888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats.
    See RE; Lynch AM; Aravagiri M; Nemeroff CB; Owens MJ
    Brain Res; 1995 Dec; 704(2):202-9. PubMed ID: 8788915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
    Hernandez L; Baptista T; Hoebel BG
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S17-35. PubMed ID: 2097671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of dopamine metabolism with local cerebral glucose utilization in rat brain following the administration of haloperidol decanoate.
    Kurachi M; Yasui S; Shibata R; Murata M; Hagino H; Kurachi T; Tanii Y; Kurata K
    Biol Psychiatry; 1994 Jul; 36(2):110-7. PubMed ID: 7948443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):251-60. PubMed ID: 2477259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain.
    Chang WH; Jaw SS; Tsay L
    Eur J Pharmacol; 1989 Mar; 162(1):151-6. PubMed ID: 2721561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
    Salminen O; Seppä T; Gäddnäs H; Ahtee L
    J Neurosci; 1999 Sep; 19(18):8145-51. PubMed ID: 10479714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.